ImmuCell Corporation (ICCC) NASDAQ

5.89

-0.14(-2.32%)

Updated at September 29 03:59PM

Currency In USD

ImmuCell Corporation

Address

56 Evergreen Drive

Portland, ME 04103

United States of America

Phone

207 878 2770

Sector

Healthcare

Industry

Biotechnology

Employees

69

First IPO Date

May 05, 1987

Key Executives

NameTitlePayYear Born
Mr. Michael F. BrighamPresident, Chief Executive Officer, Treasurer, Secretary & Director392,6091961
Ms. Bobbi Jo BrockmannVice President of Sales & Marketing and Director364,4031977
Mr. A. Gustavo ScaffaSenior Director of Quality0N/A
John W. ZinckgrafDirector of Product Development0N/A
Mr. Timothy C. FioriChief Financial Officer01979
Ms. Elizabeth S. ToothakerDirector of Finance & Administration and Controller0N/A

Description

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.